Nikolaj Sørensen
Chief Executive Officer bij OREXO AB
Vermogen: 242 087 $ op 31-03-2024
Profiel
Nikolaj Sørensen is currently the President & Chief Executive Officer at Orexo AB since 2013.
He is also the Chief Executive Officer & Director at Biolipox AB.
In addition, he holds the position of Independent Director at Moberg Pharma AB since 2021 and Director at Gesynta Pharma AB.
Mr. Sørensen previously served as an Independent Director at Bioservo Technologies AB from 2019 to 2023.
He was also a Director at Läkemedelsindustriföreningens Service AB and Pfizer AB, where he held the position of Director-European & Canada Marketing.
Before that, he worked as a Building Constructor at A.A.G.
Aalborg Gummivarefabrik A.
He started his career as a Project Leader at The Boston Consulting Group AB from 2001 to 2004.
Mr. Sørensen completed his undergraduate and graduate studies at Copenhagen Business School.
He also holds a graduate degree from Stockholm School of Economics.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
OREXO AB
0.48% | 28-02-2024 | 166 145 ( 0.48% ) | 242 087 $ | 31-03-2024 |
Actieve functies van Nikolaj Sørensen
| Bedrijven | Functie | Begin |
|---|---|---|
| OREXO AB | Chief Executive Officer | 05-02-2013 |
| MOBERG PHARMA AB | Director/Board Member | 01-01-2021 |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Chief Executive Officer | - |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Director/Board Member | - |
Eerdere bekende functies van Nikolaj Sørensen
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOSERVO TECHNOLOGIES AB | Director/Board Member | 18-12-2023 |
A.A.G. Aalborg Gummivarefabrik A/S
 A.A.G. Aalborg Gummivarefabrik A/S Miscellaneous ManufacturingProducer Manufacturing A.A.G. Aalborg Gummivarefabrik A/S is a holding company engage in manufacturing and processing technical rubber products. Its products include sheeting and plates, profiles, gaskets, pur and plastic, stable mats, mats and flooring, polyvinyl chloride doors, and accessories. It also offers items such as vibration insulators, rubber protectors and footings, custom made fender, polyurethane, playgrounds, damper, and scraper flooring solutions. The company was founded on June 29, 1979 and is headquartered in Norresundby, Denmark. | Corporate Officer/Principal | 01-07-2015 |
| The Boston Consulting Group AB | Corporate Officer/Principal | 01-01-2004 |
| Pfizer AB | Sales & Marketing | - |
| Läkemedelsindustriföreningens Service AB | Director/Board Member | - |
Opleiding van Nikolaj Sørensen
| Copenhagen Business School | Graduate Degree |
| Stockholm School of Economics | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| OREXO AB | Health Technology |
| BIOSERVO TECHNOLOGIES AB | Health Technology |
| MOBERG PHARMA AB | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Health Technology |
A.A.G. Aalborg Gummivarefabrik A/S
A.A.G. Aalborg Gummivarefabrik A/S Miscellaneous ManufacturingProducer Manufacturing A.A.G. Aalborg Gummivarefabrik A/S is a holding company engage in manufacturing and processing technical rubber products. Its products include sheeting and plates, profiles, gaskets, pur and plastic, stable mats, mats and flooring, polyvinyl chloride doors, and accessories. It also offers items such as vibration insulators, rubber protectors and footings, custom made fender, polyurethane, playgrounds, damper, and scraper flooring solutions. The company was founded on June 29, 1979 and is headquartered in Norresundby, Denmark. | Producer Manufacturing |
| The Boston Consulting Group AB | |
| Läkemedelsindustriföreningens Service AB | |
| Pfizer AB | |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Health Technology |
